In this issue of Urologic Clinics of North America, guest editor Dr. Craig V. Comiter brings his considerable expertise to the topic of Urologic Pharmacology. Medical therapies for benign prostatic hyperplasia, erectile dysfunction, hypogonadism, overactive bladder, and prostate cancer are widely available, and a basic understanding of the pharmacology of existing treatment options are necessary to avoid complications and maximize efficacy associated with patient outcomes. In this issue, top experts in the field provide current clinical information to help urologists effectively and quickly treat patients.
Medical Treatment of Hypogonadism in Men Pharmacotherapy for Erectile Dysfunction in 2021 and Beyond Medical Treatment of Disorders of Ejaculation Medical Treatment of Benign Prostatic Hyperplasia Nutraceuticals and Phytotherapy in Mens Health: Antioxidants, Pro-oxidants, and a Novel Opportunity for Lifestyle Changes Medical Treatment of Overactive Bladder Chemodenervation in Urology Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome Medical Treatment for Urinary Tract Infections Medical Treatment of Female Sexual Dysfunction Hormone Treatment of Prostate Cancer:: Evidence for Usage and Safety Immunotherapy and Checkpoint Inhibitors in Urologic Cancer Medical Treatment and Prevention of Urinary Stone Disease Immunosuppression Therapy in Kidney Transplantation
Komentarze (0)
Chwilowo nie możesz polubić tej opinii
Zgłoś komentarz
Czy jesteś pewien, że chcesz zgłosić ten komentarz?
Zgłoszenie wysłane
Twój komentarz został wysłany i będzie widoczny po zatwierdzeniu przez moderatora.